BioLineRx Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LPL FINANCIAL LLC | 02/11/2025 | 92.00 K | $19.69 K | 0.00% | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 87.22 K | $18.53 K | 383.67% | 0.01% |
| MORGAN STANLEY | 05/15/2025 | 79.10 K | $16.93 K | -59.96% | 0.01% |
| CITADEL ADVISORS LLC | 02/14/2025 | 75.10 K | $15.96 K | 61.51% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 57.34 K | $12.27 K | 100.00% | 0.00% |
| ORIN GREEN FINANCIAL, LLC | 02/19/2025 | 51.00 K | $10.91 K | 18.60% | 0.00% |
| RHUMBLINE ADVISERS | 05/29/2025 | 42.96 K | $9.15 K | 31.74% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 35.31 K | $7.56 K | 100.00% | 0.00% |
| RATHBONES GROUP PLC | 02/13/2025 | 31.67 K | $6.78 K | -20.48% | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 02/12/2025 | 1.01 M | $214.63 K | 100.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/14/2025 | 20.20 K | $4.00 K | 100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2025 | 15.31 K | $3.25 K | 100.00% | 0.00% |
| CREATIVE PLANNING | 02/14/2025 | 12.98 K | $2.78 K | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 11.94 K | $2.54 K | -8.44% | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 03/17/2025 | 10.50 K | $2.25 K | 0.00% | 0.00% |
| UBS GROUP AG | 02/14/2025 | 9.20 K | $1.97 K | 834.55% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2025 | 5.10 K | $1.08 K | -19.05% | 0.00% |
| NEWEDGE ADVISORS, LLC | 02/13/2025 | 4.30 K | $920 | 0.00% | 0.00% |
| VALUES FIRST ADVISORS, INC. | 01/29/2025 | 166.45 K | $35.62 K | -15.73% | 0.00% |
| ATRIA WEALTH SOLUTIONS, INC. | 01/31/2025 | 94.13 K | $20.14 K | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 06/06/2025 | 1.21 K | $258 | 0.00% | 0.00% |
| GRADIENT INVESTMENTS LLC | 01/21/2025 | 41.40 K | $8.86 K | 38.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 39.99 K | $8.50 K | 0.00% | 0.00% |
| WATTS GWILLIAM & CO., LLC | 01/10/2025 | 34.00 K | $5.44 K | 100.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 31.34 K | $6.66 K | 100.00% | 0.00% |
| NEMES RUSH GROUP LLC | 02/12/2025 | 12.00 K | $2.57 K | 0.00% | 0.00% |
| WEAVER CONSULTING GROUP | 01/08/2025 | 11.00 K | $2.35 K | -63.02% | 0.00% |
| HIBERNIA WEALTH PARTNERS, LLC | 01/29/2025 | 10.00 K | $2.14 K | 100.00% | 0.00% |
| NEVILLE RODIE & SHAW INC | 01/06/2025 | 10.00 K | $2.00 K | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 5.54 K | $1.18 K | -84.20% | 0.00% |
| GENEOS WEALTH MANAGEMENT INC. | 01/21/2025 | 4.80 K | $1.01 K | 6.67% | 0.00% |
| 02/06/2025 | 3.10 K | $664 | 100.00% | 0.00% | |
| TRADEWINDS CAPITAL MANAGEMENT, LLC | 02/04/2025 | 200 | $43 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| PVG ASSET MANAGEMENT CORP | 02/21/2025 | 0 | $0 | -100.00% | 0.00% |
| CUTTER & CO BROKERAGE, INC. | 02/04/2025 | 0 | $0 | -100.00% | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| ATRIA INVESTMENTS, INC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
| BAADER BANK AKTIENGESELLSCHAFT | 01/23/2025 | 0 | $0 | -100.00% | 0.00% |
| CETERA INVESTMENT ADVISERS | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioLineRx Ltd. institutional Ownership - FAQ's
During the previous two years, 37 institutional investors and hedge funds held shares of BioLineRx Ltd.. The most heavily invested institutionals were:
NewEdge Advisors, LLC: 0
RHUMBLINE ADVISERS: 0
Nemes Rush Group LLC: 0
HIGHBRIDGE CAPITAL MANAGEMENT LLC: 0
Qube Research & Technologies Ltd: 0
UBS Group AG: 0
0.00% of BioLineRx Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 865.75 K shares in the last 24 months. This purchase volume represents approximately $3.46 M in transactions.